Winston-Salem.

WINSTON-SALEM--Targacept's CEO and president J. Donald deBethizy stepped down after the failure of two drug candidates in clinical trials during the past year sank the company's share price. The biopharmaceutical company has created an office of the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT